Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients
Prescriptions of GLP-1RAs and SGLT2 inhibitors in type 1 diabetes patients rose from 2010 to 2023, especially among those with elevated cardiorenal risk.
Study: GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in…
Read More...
Read More...